Contractor
DUKE UNIVERSITY
- UEI
- TP7EK8DZV6N5
- Parent UEI
- TP7EK8DZV6N5
- Resolved by
- uei
- Confidence
- 1.000
Active from Sep 27, 2012 to Oct 15, 2026.
Sign in to watchWhat they win
Benchmark categories this contractor appears in, by award count.
| Category | Awards | Obligated |
|---|---|---|
| Program Management Support | 1 | $200,000 |
| Software Development | 1 | $98,394 |
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 80NSSC23PA147 NASA MEMBERSHIP IN GUIDE 7 TURBOPUMP RESEARCH CONSORTIUM | National Aeronautics and Space Administration | NC | Dec 8, 2022 | $200,000 |
| 75N93026D00009 IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA) | Department of Health and Human Services | — | Sep 30, 2026 | — |
| 75N93019C00054 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020) | Department of Health and Human Services | NC | Sep 16, 2019 | $35,619,447 |
| 7571MN26C00048 NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATIONS AND MAINTENANCE (O&M) SERVICES FOR ACF/CB THIS IS A DOI CONTRACT #140D0422P0227, THAT IS TRANSFERRED TO HHS/ASFR/OMAS. | Department of Health and Human Services | NC | Sep 29, 2026 | $1,395,988 |
| 75F40126C00081 EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP1 VALID APPROACHES TO INTEGRATING PATIENT SCIENCE INTO MEDICAL DEVICE STUDIES | Department of Health and Human Services | NC | Sep 26, 2026 | $749,762 |
| 75N93019C00053 COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE | Department of Health and Human Services | NC | Aug 26, 2019 | $77,629,982 |
| 75D30126F00004 CISA HOME LAIV STUDY- LEAD SITE, EO 14398 | Department of Health and Human Services | NC | Sep 25, 2026 | $1,869,870 |
| 75N94026F00002 NICHD: R&D: BESPOKE GENE THERAPY CONSORTIUM (BGTC) - SUPPORT FOR NIH-SPONSORED CLINICAL TRIALS: NON-SEVERABLE | Department of Health and Human Services | NC | Sep 24, 2026 | $8,301,883 |
| 75F40126C00112 EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE - CORE CLINICAL OUTCOME ASSESSMENT GRANT PROGRAM | Department of Health and Human Services | NC | Sep 24, 2026 | $1,456,427 |
| 123A9426P0037 UNTARGETED METABOLOMIC ANALYSIS OF PLANT EXTRACTS (SUGARCANE) FOR THE COMMODITY UTILIZATION RESEARCH UNIT AT SRRC. | Department of Agriculture | NC | Sep 22, 2026 | $30,012 |
| 75F40125C00053 THE FOOD AND DRUG ADMINISTRATION (FDA) IS RESPONSIBLE FOR PROTECTING THE PUBLIC HEALTH BY ASSURING THE SAFETY, EFFICACY, AND SECURITY OF HUMAN AND VETERINARY DRUGS, BIOLOGICAL PRODUCTS, MEDICAL DEVICES, OUR NATION?S FOOD SUPPLY, COSMETICS, AND PRODUC | Department of Health and Human Services | NC | Sep 8, 2025 | $749,661 |
| 75N94026F00001 NICHD: R&D: INNOVATIVE TRIAL DESIGNS AND LABS 2.0: NON-SEVERABLE | Department of Health and Human Services | NC | Sep 21, 2026 | $5,699,498 |
| 75D30121D12733 SHEPHERD IDIQ 2021-2026 DOMAINS 1,2,4 &5 | Department of Health and Human Services | — | Sep 27, 2021 | — |
| 75N93022C00055 "ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES" | Department of Health and Human Services | NC | Sep 19, 2022 | $18,032,121 |
| 75F40126C00181 FIRM FIXED PRICE AWARD TOWARDS ML-POWERED, EFFICIENT AND ROBUST INFERENCE OF AVERAGE AND INDIVIDUAL TREATMENT EFFECTS FOR NOVEL CLINICAL TRIALS IN RARE DISEASES CONTRACTING OFFICER REPRESENTATIVE: DEBORAH ELLIOTT TELEPHONE: (240) 397-3022 DEBO | Department of Health and Human Services | MD | Sep 18, 2026 | $1,256,810 |
| 75N94021F00001 BPCA PHARMACOEPIDEMIOLOGY (REAL WORLD DATA) STUDIES | Department of Health and Human Services | NC | Aug 16, 2021 | $2,394,452 |
| 75N94019F00126 TO PROVIDE A PLATFORM FOR THE INCLUSION OF PATIENTS WITH DOWN SYNDROME INTO THE PHARMACOLOGY-BASED CLINICAL TRIALS. THE GOALS ARE TO RECRUIT THIS PATIENT POPULATION INTO THE PEDIATRIC TRIALS NETWORK OPPORTUNISTIC STUDY MODEL AND TO DEVELOP A TRAINING | Department of Health and Human Services | NC | Sep 11, 2019 | $6,796,098 |
| 75N94021F00003 PHARMACEUTICALS (PK) AND SAFETY OF COMMONLY USED DRUGS IN LACTATING WOMEN AND BREASTFED INFANTS (CUDDLE 2.0) NETWORK | Department of Health and Human Services | NC | Sep 23, 2021 | $3,938,833 |
| 75N93021C00010 IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM | Department of Health and Human Services | NC | Jun 15, 2021 | $10,850,736 |
| 36C24626P1069 MRI RESEARCH SERVICES | Department of Veterans Affairs | NC | Sep 14, 2026 | $18,095 |
| 75D30123F00001 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | Department of Health and Human Services | NC | Sep 26, 2023 | $738,072 |
| 75F40124C00083 BAA BENEFIT-TRANSFER METHODS ON DIABETES MEDICAL DEVICES FY24C1IP2 DPCD | Department of Health and Human Services | NC | Jul 24, 2024 | $699,087 |
| 75N94025F00002 NICHD: R&D: BPCA PEDIATRIC DRUG DEVELOPMENT CLINICAL TRIAL INFRASTRUCTURE: SEVERABLE | Department of Health and Human Services | NC | Jul 25, 2025 | $4,996,766 |
| 36C24623P1586 BRAIN TISSUE PROCESSING WITH DUKE UNIVERSITY | Department of Veterans Affairs | NC | Sep 13, 2023 | $2,328,226 |
| 75D30123F00002 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | Department of Health and Human Services | NC | Sep 27, 2023 | $2,171,300 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier TP7EK8DZV6N5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.